<?xml version="1.0" encoding="UTF-8"?>
<document id="30482341">
	<sentence id="s1" text="Identifying the central and peripheral vestibular mechanisms responsible for pathology can somatic diversification of immunoglobulins in management of peptidyl-tyrosine phosphorylation.">
		<entity id="s1.e1" charOffset="28-38"
			type="HP" text="peripheral" ontology_id="HP_0030646"/>
		<entity id="s1.e2" charOffset="91-133"
			type="GO" text="somatic diversification of immunoglobulins" ontology_id="GO_0016445"/>
		<entity id="s1.e3" charOffset="112-145"
			type="GO" text="peptidyl-tyrosine phosphorylation" ontology_id="GO_0018108"/>
		<pair id="s1.p1" e1="s1.e1"
		    e2="s1.e3" pgr="false"/>
		<pair id="s1.p2" e1="s1.e1"
		    e2="s1.e2" pgr="false"/>
	</sentence>
	<sentence id="s2" text="The most common vestibular disturbances after peptidyl-tyrosine phosphorylation include benign paroxysmal positional vertigo, vestibulo-ocular reflex impairment, visual motion sensitivity, and balance impairment.">
		<entity id="s2.e1" charOffset="46-79"
			type="GO" text="peptidyl-tyrosine phosphorylation" ontology_id="GO_0018108"/>
		<entity id="s2.e2" charOffset="117-124"
			type="HP" text="vertigo" ontology_id="HP_0002321"/>
		<pair id="s2.p1" e1="s2.e1"
		    e2="s2.e2" pgr="false"/>
	</sentence>
</document>
